Next Phase Newsletter

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

With less than 2 months left until LSN’s next conference, RESI JPM 2024, we are very excited to announce the 50+ Innovator’s Pitch Challenge (IPC) finalists who will be pitching to a panel of investors and industry experts and showcasing their posters throughout the day of RESI. All RESI JPM attendees will be able to view their pitches, visit their posters, and “invest” in their favorite companies. After counting these votes, we will announce the Top 3 winners during the cocktail reception at the end of RESI.

We are pleased to work with companies who are sponsored by the following organizations: NIH’s Small Business Education and Entrepreneurial Development (SEED) Office, National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), and Brisbane Economic Development Agency (BEDA).

Please review the companies below, and if you are interested in attending RESI JPM 2024 and learning more about the different registration options we offer, please visit here

RESI JPM 2024 IPC Finalists

By Karen Deyo, VP of Product, Israel BD, LSN

Life Science Nation (LSN)‘s flagship RESI conference – RESI JPM, will take place at the Marine’s Memorial Club & Hotel in San Francisco on Tuesday, January 9, 2024, followed by two days of virtual partnering, during JP Morgan Healthcare Week. In preparation for our conference attendees to maximize their partnering efforts we have compiled steps to craft an effective messaging plan to fill your partnering calendar.

Partnering is an involved process with multiple steps that must be taken to ensure optimal results. These steps often require a major time investment, and we forget that even after the hours we’ve poured into the process, none of it matters without a compelling message to pique the interest of a potential partner. Furthermore, this is a process that requires a plan for following up, since, as with any outreach, it will likely take more than one message to the investors to receive a response. These messages should be clear and concise, no more than a paragraph, highlighting your company and what makes it unique.

LSN has developed and consolidated your partnering outreach into four separate messages:

• Introduction: The first message is the one where you introduce yourself and your company, as well as request a meeting. It’s ok if your target investor does not respond immediately (hence this system). To help them understand your position, it’s important to include the following:
• Company tagline (5-6 words explaining who you are and what you do)
• Elevator pitch (1-3 sentences describing the company and tech)
• Technology differentiation, product innovation, or market position
• Raise and milestone information
• Follow-Up 1 (Product/Tech): Why is your product and technology unique? Is it first-in-class? Best-in-class? This is your opportunity to dive into your company’s differentiated value.
• Follow-Up 2 (Management/Team): Highlight your management and team. How have your people had a notable impact on business development? What makes your people special?
• Follow-Up 3 (One-Pager): Condense all the important messages you’ve already shared into a one-page tear sheet for quick and easy reference later.

It should go without saying that the perfect message is meaningless without a well-researched and formulated target list and marketing collateral at the ready. Think of the perfect message like how an athlete approaches the arena on game day. It’s the starting shot of a long and exciting process. It won’t replace the training and conditioning that got you to game day, but it’ll ensure you’re off with a competitive edge.

Tuesday, December 19, 12PM ET | Partnering Tutorial – Sign Up

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

RESI JPM will feature the Global Family Office BioForum, for both sourcing assets and identifying syndication partners bridging the gap between family offices and investment opportunities within the life sciences sector. The Global Family Office BioForum will feature an open-to-the-public Global Family Office Panel as part of the RESI program and an invitation-only luncheon that will have a keynote by Michael Langer, discussing his Langer Family Office initiatives, including early-stage investment, sourcing and vetting technology assets, and working with partnership opportunities.

As the life sciences sector burgeons with groundbreaking discoveries, therapies, and technologies, the need for early capital injection becomes ever more pronounced. The Global Family Office BioForum is a convergence point where family offices can simultaneously identify promising startups and collaborate with other like-minded investors.

The Power of Syndication

Syndication has emerged as a dynamic strategy in the investment landscape, offering distinct advantages to family offices and entrepreneurs seeking funding. Family offices can diversify risk and share due diligence efforts by joining forces with other investors in a syndicate. This collaborative approach allows investors to tap into a broader range of investment opportunities and capitalize on their combined expertise. Conversely, entrepreneurs benefit from access to a syndicate’s collective knowledge and resources, expediting fundraising and enhancing their chances of securing the necessary funds.

The Family Office Factor

Family offices are known for their long-term investment outlook and commitment to fostering meaningful impact. With a mission to preserve and grow their wealth across generations, family offices are uniquely positioned to contribute to the life sciences sector. Their involvement goes beyond monetary support; it encompasses mentorship, guidance, and a vested interest in the success of the ventures they invest in. The Global Family Office BioForum acknowledges this distinctive role and seeks to create an environment where family offices can connect with like-minded syndicate partners and explore transformative investment opportunities. Life Science Nation is excited to bring this factor to the RESI JPM conference again.